The role of antifungal treatment in hematology.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer.The Cochrane database of systematic reviews · 2022
   Pooled it
2. Diagnosis and risk factors for invasive mould disease-a round table discussion on directing antifungal therapy according to the available evidence.The Journal of antimicrobial chemotherapy · 2026
   Article
3. Patterns and Drivers of Antifungal Prescribing in Acute Leukemia: A Retrospective Cohort Study.Open forum infectious diseases · 2024
   Article
4. Survival Outcome of Empirical Antifungal Therapy and the Value of Early Initiation: A Review of the Last Decade.Journal of fungi (Basel, Switzerland) · 2022
   Review
5. Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy.Scientific reports · 2021
   Article
6. A Prospective Multicenter Cohort Surveillance Study of Invasive Aspergillosis in Patients with Hematologic Malignancies in Greece: Impact of the Revised EORTC/MSGERC 2020 Criteria.Journal of fungi (Basel, Switzerland) · 2021
   Article
7. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.Medical mycology · 2019
   Article
8. Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.BMC infectious diseases · 2018
   Article
9. The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center StudyTurkish journal of haematology : official journal of Turkish Society of Haematology · 2018
   Article
10. Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
11. Adherence to, and outcomes of, a galactomannan screening protocol in high-risk hematology patients.Current oncology (Toronto, Ont.) · 2018
    Article
12. Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis.ESMO open · 2018
    Review
13. Immunomodulation as Therapy for Fungal Infection: Are We Closer?Frontiers in microbiology · 2018
    Review
14. Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Observational
15. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.Journal of clinical microbiology · 2015
    Article
16. High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan.PloS one · 2015
    Observational
17. An iron-mimicking, Trojan horse-entering fungi--has the time come for molecular imaging of fungal infections?PLoS pathogens · 2015
    Article
18. Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing.PloS one · 2014
    Article
19. Cost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia.Antimicrobial agents and chemotherapy · 2013
    Article
20. The diagnostic role of galactomannan during antifungal prophylaxis. Comment on: "The role of antifungal treatment in hematology". Haematologica 2012;97(3):325-7.Haematologica · 2012
    Article

Corrections and comments

• Commented on by
  The diagnostic role of galactomannan during antifungal prophylaxis. Comment on: "The role of antifungal treatment in hematology". Haematologica 2012;97(3):325-7.2012

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as